Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system

Acta Neuropathologica

Volumn 91, Issue 3, 1996, Pages 254-262

  Mizuguchi, Masashi ^a   Tanaka, Soichiro ^a   Fujii, Ikuko ^b   Tanizawa, Hisayuki ^b   Suzuki, Yasuo ^b   Igarashi, Takashi ^c,d   Yamanaka, Tatsuhiro ^c,d   Takeda, Tae ^e   Miwa, Masao ^b  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^d Yaizu Municipal Hospital   (Japan)

^e NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Acute encephalopathy; Cerebral infarction; Hemolytic uremic syndrome; Immunohistochemistry; Verocytotoxin producing Escherichia coli

Indexed keywords

VEROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY WALL; ARTICLE; ATROPHY; BLOOD BRAIN BARRIER; BRAIN INFARCTION; CELL NUCLEUS; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; ESCHERICHIA COLI; IMMUNOHISTOCHEMISTRY; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CELL; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PARALYSIS; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; THICKNESS; VASCULAR DISEASE;

ANIMALS; BACTERIAL TOXINS; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR CIRCULATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; MALE; NEURONS; RABBITS; SHIGA-LIKE TOXIN II;

EID: 0030031868     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050423     Document Type: Article

References (33)

1. Bale JF, Brasher C, Siegler RL (1980) CNS manifestations of the hemolytic-uremic syndrome. Am J Dis Child 134: 869-872
2. Bos AP, Donckerwolcke RA, Vught AJ van (1985) The hemolytic-uremic syndrome: prognostic value of neurological abnormalities. Helv Paediatr Acta 40: 381-389
3. Bridgwater FAJ, Morgan RS, Rowson KEK, Wright GP (1955) The neurotoxin of Shigella shigae. Morphological and functional lesions produced in the central nervous system of rabbits. Br J Exp Pathol 36: 447-453
4. Cimolai N, Morrison BJ, Carter JE (1992) Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome. Pediatrics 90: 616-621
5. Crisp DE, Sieger RL, Thompson JA (1981) Hemorrhagic cerebral infarction in the hemolytic-uremic syndrome. J Pediatr 99: 273-276
6. DiMario FJ, Bronte-Stewart H, Sherbotie J, Turner ME (1987) Lacunar infarction of the basal ganglia as a complication of hemolytic-uremic syndrome. Clin Pediatr 26: 586-590
7. Fujii J, Kita T, Yoshida S-I, Takeda T, Kobayashi H, Tanaka N, Ohsato K, Mizuguchi Y (1994) Direct evidence of neuron impairment by oral infection with verotoxin-produced Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun 62: 3447-3453
8. Hahn JS, Havens PL, Higgins JJ, O'Rourke PP, Estroff JA, Strand R (1989) Neurological complications of hemolytic-uremic syndrome. J Child Neurol 4: 108-113
9. Hamano S, Nakanishi Y, Naka T, Seki T, Ohtani T, Oishi T, Joh K, Oikawa T, Muramatsu Y, Ogawa Y, Akashi S (1991) Neurological manifestations of hemorrhagic colitis in the out-break of Escherichia coli O157:H7 infection in Japan. Acta Pediatr 82: 454-458
10. Howard JG (1955) Observations on the intoxication produced in mice and rabbits by the neurotoxin of Shigella shigae. Br J Exp Pathol 36: 439-446
11. Karmali M, Petric M, Lim C (1985) The association between idiopathic hemolytic-uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151: 775-782
12. Kavi J, Wise R (1989) Causes of the haemolytic uraemic syndrome: it might be verocytotoxin produced by Escherichia coli. Br Med J 298: 65-66
13. Kleanthous H, Smith HR, Scotland R, Gross J, Rowe B, Taylor CM, Milford DV (1990) Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. 2. Microbiological aspects. Arch Dis Child 65: 722-727
14. Mendelsohn DB, Hartzanu Y, Chaitowitz B, Cartwright JD (1984) Cranial CT in the haemolytic uraemic syndrome. J Neuron Neurosurg Psychiatry 47: 876-878
15. Milford DV, Taylor CM, Guttridge B, Hall SM, Rowe B, Kleanthous H (1990) Haemolytic uraemic syndromes in the British Isles. 1985-8: association with verocytotoxin producing Escherichia coli. 1. Clinical and epidemiological aspects. Arch Dis Child 65: 716-721
16. Mizuguchi M, Yamada M, Rhee SG, Kim SU (1992) Development of inositol 1,4,5-trisphosphate 3-kinase immunoreactivity in cerebellar Purkinje cells in vivo and vitro. Brain Res 573: 157-160
17. O'Brien AD, Holmes RK (1987) Shiga and Shiga-like toxins. Microbiol Rev 51: 206-220
18. Ostruff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, Kobayashi JM (1989) Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157: H7 infections. J Infect Dis 160: 994-998
19. Rasoulpour M, Leichtner A, San Jorge M, Hyams J (1985) Cerebral vascular accident during the recovery phase of hemolytic-uremic syndrome. Int J Pediatr Nephrol 6: 287-288
20. Richadson SE, Rotman TA, Jay V, Smith CR, Becker LE, Petric M, Olivieri NF, Karmali MA (1992) Experimental verocytotoxinemia in rabbit. Infect Immun 60: 4154-4167
21. Rooney JC, Anderson RM, Hopkins U (1971) Clinical and pathological aspects of central nervous system involvement in the haemolytic uraemic syndrome. Aust Pediatr J 7: 28-33
22. Scotland SM, Willshaw GA, Smith HR, Rowe B (1987) Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect 99: 613-624
23. Sherwood JW, Wagle WA (1991) Hemolytic-uremic syndrome: MR findings of CNS complications. Am J Neuroradiol 12: 703-704
24. Sheth KJ, Swick HM, Harworth N (1986) Neurological involvement in hemolytic-uremic syndrome. Ann Neurol 19: 90-93
25. Siegler RL (1994) Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr 125: 511-518
26. Siegler RL, Pavia AT, Christofferson RD, Milligan MK (1994) A 20-year population-based study of post-diarrheal hemolyticuremic syndrome in Utah. Pediatrics 94: 35-40
27. Steele BT, Murphy N, Chuang SH, McGreal D, Arbus GS (1983) Recovery from prolonged coma in hemolytic uremic syndrome. J Pediatr 102: 402-404
28. Steinberg A, Ish-Horowictz M, El-Peleg O, Mor J, Branski D (1986) Stroke in a patient with hemolytic-uremic syndrome with a good outcome. Brain Dev 8: 70-72
29. Strockbine NA, Marques LRM, Newland JW, Smith HW, Holmes RK, O'Brien AD (1986) Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun 53: 135-140
30. Tziposi S, Chow CW, Powell HR (1988) Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets. J Clin Pathol 41: 1099-1103
31. Upadhyaya K, Barwick K, Fishaut M, Kashgarian M, Siegel NJ (1980) The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics 65: 115-120
32. Yutsudo T, Nakabayashi N, Hirayama T, Takeda Y (1987) Purification and some properties of a vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb Pathog 3:21-30
33. Zoja C, Coma D, Farina C, Sacchi G, Lingwood C, Doyle MP, Padhye VV, Abbate M, Remutti G (1992) Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J Lab Clin Med 120: 229-238